Pfizer stock edges up on HHS drug price deal

Published on 09/20/2026 at 12:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Pfizer stock traded at USD 27.62 on September 19, 2026, with a market value of USD 157.34 billion. MarketBeat put the consensus at Hold and the average target at USD 28.39.

Fotorealistische unbeschriftete Pharma-Anlage bei Dämmerung, Symbolbild für Pfizer Inc — Fotorealistische Pharma-Produktionsanlage bei Dämmerung symbolisiert Pfizer Inc. mit ISIN US7170811035 im Biotech-Sektor, Illustration mit AI erstellt.

Pfizer Inc. (ISIN US7170811035) stock traded at USD 27.62 on September 19, 2026, with a market capitalization of USD 157.34 billion and volume of 75.59 million shares. The move came as Bloomberg reported on September 19, 2026, that the U.S. Department of Health and Human Services would get a portion of any increased revenue if Pfizer charges higher drug prices abroad.

Revenue and guidance

MarketBeat said on September 20, 2026, that Pfizer's latest quarterly figures showed adjusted EPS of USD 0.77 and revenue of USD 15.03 billion, with revenue up 2.6 percent year over year. The same report said Pfizer reaffirmed full-year 2026 earnings guidance of USD 2.80 to USD 3.00 per share.

The same source also said the stock has a 1-year high of USD 29.21 and a 1-year low of USD 23.58, while the quarterly dividend was USD 0.43 per share and the dividend payout ratio stood at 226.32 percent. For investors, the guidance range and payout ratio are now the key numbers.

Analysts stay cautious

According to MarketBeat on September 20, 2026, 14 of 21 analysts rated Pfizer Hold, while four called it Buy and two Sell, leaving the consensus at Hold. The same update put the average 12-month price target at USD 28.39, only slightly above the last quoted price.

MarketBeat also listed Pfizer's debt-to-equity ratio at 0.71, current ratio at 1.27 and quick ratio at 0.96. That mix keeps the balance-sheet picture tighter than the sales figure alone suggests.

Stock near the high end

Pfizer stock changed hands at USD 27.62 on September 19, 2026, just below the 1-year high of USD 29.21 and above the 1-year low of USD 23.58. The company also carried a market capitalization of USD 157.34 billion and a dividend yield of 6.22 percent at that snapshot.